CSI Market
Sign In | Register

Phoenix Biotech Acquisition (PBAXU) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PBAXU Annual Balance Sheets →
This balance sheet overview for Phoenix Biotech Acquisition spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.86
Restricted Cash and Cash Equivalents, Current0.03
Cash & Short-term Investments0.00
Deferred Costs, Current AS0.00
Other Current Assets0.05
Prepaid Expense And Other Assets Current0.61
Total Current Assets1.55
Equipment/Property/Plant Net2.55
Tax Assets, Noncurrent0.00
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.86
Equity Securities Fv Ni-
Operating Lease Right Of Use Asset0.45
Total Assets1.90
Liabilities
Accounts Payable, Current AC8.22
Accrued Liabilities, Current AC0.49
Derivative Liability, Current DE7.66
Short-term Bank Loans and Notes Payable SH0.75
Other Liabilities, Current15.29
Accrued Income Taxes, Current TA0.00
Total Current Liabilities32.41
Long-term debt0.75
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.75
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Earnout Liability Current0.00
Operating Lease Liability Current0.46
Total Liabilities32.41
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock65.96
Retained Earnings / Accumulated Deficit-97.75
Other Equity0.00
Common Stockholder's Equity-45.48
Preferred Stockholder's Equity14.97
Total Stockholder's Equity-30.51
Liabilities & Stockholder's Equity1.90
4 historic quarters locked

Sign in to unlock the full Phoenix Biotech Acquisition balance sheet history.

Sign In Create Free Account

About Cero Therapeutics Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090030

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.